drug threats in the united states: 2019 update · 2019-03-13 · 2 1 1 1 1 2c-b 25i-nbome 25b-nbome...

30
Drug Threats in the United States: 2019 Update JILL M. HEAD SPECIAL TESTING AND RESEARCH LABORATORY DRUG ENFORCEMENT ADMINISTRATION DEA SPECIAL TESTING AND RESEARCH LABORATORY

Upload: others

Post on 11-Mar-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Drug Threats in the United States: 2019 Update

J I L L M . H E A DS P E C I A L T E S T I N G A N D R E S E A R C H L A B O R AT O R YD R U G E N F O R C E M E N T A D M I N I S T R AT I O N

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 2: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Objectives1. Overview of the DEA Emerging Trends & Reference Materials Programs

2. Emerging Threat Report data for CY2018

1. Synthetic Cannabinoids

2. Synthetic Cathinones

3. Fentanyl, Fentanyl-related compounds and new synthetic opioids

4. Other NPS classes

3. Seized drug composition and mixtures containing fentanyl

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 3: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Emerging Trends and Reference Material Programs

1. Analysis of domestic and foreign drug seizures

2. Research and method development for identification and quantitation

3. Authentication of reference materials

4. Structural Elucidation of unknown drugs

5. Authors SWGDRUG monographs

6. Monitors past/current trends to predict future needs

7. Publishes Emerging Threat Report

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 4: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Emerging Threats

New Psychoactive Substances (NPS)◦ A new narcotic or psychotropic drug, in

pure form or in preparation, that is not controlled by the UN drug conventions, but which may pose a public health threat

Synthetic Cannabinoids

Substituted Cathinones

Hallucinogens

Synthetic Opioids

Benzodiazepines

Plant-Derived Highs

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 5: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Forensic Chemistry AnalysisWHAT IT IS

Seized drug samples

Parent drug

WHAT IT IS NOT

Biological samples

Toxicological samples

Metabolites

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 6: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Data Sources

DEA Reporting◦ Laboratory Information Management System (LIMS)

◦ Seized: 01/01/2018 – 12/31/2018, Analyzed by 12/31/2018

Considerations◦ Backlogs

◦ Availability of reference materials

◦ Excludes analyses performed at DEA Special Testing and Research Laboratory

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 7: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DRUG ENFORCEMENT ADMINISTRATIONSPECIAL TESTING AND RESEARCH LABORATORYEMERGING TRENDS PROGRAM

Notes:1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2018 through 12/31/2018 that were

analyzed by 12/31/2018. The data was retrieved on 01/11/2019.

172

163

71

20

16

15

11

8

7

7

6

6

5

4

4

2

2

1

1

1

1

1

1

1

5F-MDMB-PINACA

FUB-AMB

ADB-FUBINACA

5F-EDMB-PINACA

5F-MDMB-PICA

MMB-CHMICA

5F-AMB

FUB-144

5F-UR-144

ADB-CHMINACA

MMB-FUBICA

NM2201

AB-PINACA

4-CN-CUMYL-BUTINACA

AB-CHMINACA

MMB-2201

MDMB-FUBINACA

5Cl-AKB48

5F-AKB48

5F-EMB-PINACA

AB-FUBINACA

FUB-AKB48

FUB-PB-22

PB-22

Synthetic Cannabinoids Seized and Identified by DEA between January 1, 2018 to December 31, 2018

526 synthetic cannabinoid identifications 5F-MDMB-PINACA and FUB-AMB was the

most reported synthetic cannabinoids (64%) 25 different substances seized and identified 7 substances identified for the first time

Page 8: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DRUG ENFORCEMENT ADMINISTRATIONSPECIAL TESTING AND RESEARCH LABORATORYEMERGING TRENDS PROGRAM

Notes:1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2018 through 12/31/2018 that were

analyzed by 12/31/2018. The data was retrieved on 01/11/2019

204

29

28

12

11

7

7

5

3

3

3

3

2

2

1

1

1

1

1

1

1

N-Ethylpentylone

N-Ethylhexedrone

Dibutylone

4-Cl-α-PVP

α-PiHP

4-CEC

4-F-α-PHP

Ethylone

4-Methylpentedrone

Pentylone

α-PPP

α-PVP

4'-Methyl-α-PHP

Methylone

4-MeAPP

4-MEC

3,4-MDDMC

N,N-Dimethylpentylone

Pentedrone

TH-PVP

α-PHP

327 synthetic cathinone identifications N-Ethylpentylone was the most reported

cathinone (62%) 22 different substances seized and identified 5 cathinones identified for the first time

Synthetic Cathinones Seized and Identified by DEA between

January 1, 2018 to December 31, 2018

Page 9: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Fentanyl and Synthetic Opioids

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 10: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Pharmaceutical Fentanyl

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 11: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DEA SPECIAL TESTING AND RESEARCH LABORATORYDEA SPECIAL TESTING AND RESEARCH LABORATORY

Valeryl fentanyl Fentanyl

Furanyl fentanyl Acetylfentanyl

Page 12: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Packaging

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 13: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Tablets

Fentanyl

acetylfentanylNew Jersey

AB-FUBINACA/etizolam/fentanyl

New York

FentanylNew Jersey

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 14: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Other Forms

FentanylCalifornia

AcetylfentanylNebraska

FentanylTexas

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 15: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DRUG ENFORCEMENT ADMINISTRATIONSPECIAL TESTING AND RESEARCH LABORATORYEMERGING TRENDS PROGRAM

Synthetic Opioids Seized in 2015

Notes:1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2015 through 12/31/2015 that were analyzed by

12/31/2016. The data was retrieved on 01/04/2017.

524

132

15

12

8

1

Fentanyl

Acetylfentanyl

Butyrylfentanyl

β-Hydroxythiofentanyl

4-ANPP

Valeryl fentanyl

Page 16: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Fentanyl-type substances

Acetyl fentanyl Fentanyl Butyryl fentanyl Valeryl fentanyl(Pentanoyl fentanyl)

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 17: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DRUG ENFORCEMENT ADMINISTRATIONSPECIAL TESTING AND RESEARCH LABORATORYEMERGING TRENDS PROGRAM

877

142

112

50

32

20

17

13

13

10

4

3

3

2

1

Fentanyl

Furanyl fentanyl

Acetylfentanyl

U-47700

4-ANPP

4-Fluoroisobutyrylfentanyl

Carfentanil

Acryl fentanyl

Butyryl fentanyl

Valerylfentanyl

o-Fluorofentanyl

Benzylfentanyl

p-Fluorobutyrylfentanyl

3-Methylfentanyl

Acetyl norfentanyl

Notes:1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2016 through 12/31/2016 that were analyzed by

12/31/2016. The data was retrieved on 01/04/2017.

Opioid & “Fentanyl-like” CY 2016 Identifications

15 different substances seized and identified in 2016

~60% of these substances were seized and reported for the first time in 2016

Page 18: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DRUG ENFORCEMENT ADMINISTRATIONSPECIAL TESTING AND RESEARCH LABORATORYEMERGING TRENDS PROGRAM

Fentanyl-type substances

β-HydroxythiofentanylCarfentanil

4-Fluoroiso-butyrfentanyl

3-Methylfentanyl

Fentanyl

Page 19: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DRUG ENFORCEMENT ADMINISTRATIONSPECIAL TESTING AND RESEARCH LABORATORYEMERGING TRENDS PROGRAM

2723

215

188

109

61

59

42

37

35

27

16

13

11

10

8

7

7

6

4

4

3

2

1

1

1

1

Fentanyl

4-ANPP

Acetylfentanyl

4-FiBF

Cyclopropylfentanyl

Methoxyacetylfentanyl

U-47700

Carfentanil

Furanyl fentanyl

Butyryl fentanyl

Valeryl fentanyl

2-Furanylbenzyl fentanyl

Benzoyl fentanyl

3-Methylfentanyl

Benzyl fentanyl

despropionyl p-fluorofentanyl

U-48800

Acryl fentanyl

2-Thiofuranyl fentanyl

Isopropyl U-47700

NPP

N-Methyl norfentanyl

4'-Methyl acetyl fentanyl

o-Methyl acetyl fentanyl

p-Fluorobutyryl fentanyl

U-49900

Notes:1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2018 through 12/31/2018 that were

analyzed by 12/31/2018. The data was retrieved on 01/11/2019.

Synthetic Opioids Seized and Identified by DEA in CY2018

~27% increase in identifications from CY2017 26 different substances seized and identified 7 substances seized and identified for the first

time

●●●●

Page 20: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DRUG ENFORCEMENT ADMINISTRATIONSPECIAL TESTING AND RESEARCH LABORATORYEMERGING TRENDS PROGRAM

Notes:1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2018 through 12/31/2018 that were

analyzed by 12/31/2018. The data was retrieved on 01/11/2019.

4

2

1

1

1

1

2C-B

25I-NBOMe

25B-NBOMe

25C-NBOMe

2C

2C-I

Hallucinogens

9

6

4

3

TFMPP

BZP

pFPP

DBZP

Piperazines

35

4

2

Etizolam

Flubromazolam

Flualprazolam

Benzodiazepines

OtherSubstance Unconfirmed 92

Mitragynine 12

3-MeO-PCP 7

2F-Deschloroketamine 3

2-Oxo-PCE 3

MMMP 3

4-Fluoroamphetamine 2

Unknown 2

Yohimbine 2

3-Fluorophenmetrazine 1

5-MeO-DALT 1

5-MeO-DiPT 1

DMAA 1

Page 21: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

FentanylA LOOK AT SEIZED DRUG MIXTURES

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 22: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Fentanyl with Heroin

4228

Cocaine 412

Methamphetamine 208

Mixtures Containing Fentanyl

Each identification was made in the same seized material• May have also contained

other substances (controlled or non-controlled)

# of Identifications

Note: This data was acquired from exhibits analyzed by the DEA Laboratory System.

Page 23: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Substances Identified Weight Region

FentanylHeroin

7986g powder South Central Region

Fentanyl Heroin (2.5%)

6.9g powder South Central Region

Heroin (5.4%)Fentanyl (4.5%)

1.9g powder Mid-Atlantic Region

Heroin (18%)Fentanyl (3.7%)

49g powder North Central Region

Heroin (21%)Fentanyl (2%)Diphenhydramine

89g powder North Central Region

HeroinFentanylProcaine

495g powder Northeastern Region

HeroinFentanylTramadolQuinine

0.5g powder Northeastern Region

Heroin (3.9%)FentanylTramadolCaffeineProcaineQuinine

998g (brick) Northeastern Region

Heroin and Fentanyl MixturesNote: This data was acquired from exhibits analyzed by the DEA Laboratory System between 9/2/2018 through 1/5/2019.

Page 24: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Substances Identified Weight Region

FentanylCocaine

0.86g powder Southeastern Region

HeroinFentanylCocaineCaffeineQuinineIbuprofenLidocaine

Residue (paraphernalia) Mid-Atlantic Region

HeroinFentanylCocaineQuinineSalicylic AcidCaffeine

4.6g powder Southeastern Region

Cocaine HydrochlorideFentanylPhenacetin

1996g powder Southwestern Region

Cocaine and Fentanyl MixturesNote: This data was acquired from exhibits analyzed by the DEA Laboratory System between 9/2/2018 through 1/5/2019.

Page 25: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Substances Identified Weight Region

HeroinFentanylMethamphetamineXylazineQuinineCaffeineDiphenhydramine

3.3g powder North Central Region

CocaineMethamphetamine06-monoacetylmorphineFentanylNoscapinePTHIT

Residue (scale) Southwestern Region

Fentanyl (4.6%)TramadolKetamineMethamphetamineNoscapineDipyrone

513g powder Southwestern Region

Fentanyl (0.8%)HeroinMethamphetamineAcetaminophenCaffeineLidocaine

5.2g tablets Northeastern Region

Methamphetamine and Fentanyl MixturesNote: This data was acquired from exhibits analyzed by the DEA Laboratory System between 9/2/2018 through 1/5/2019.

Page 26: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Substances Identified Weight Region

CocaineHeroin2-Furanyl fentanylFentanylCaffeineQuinineBenzocainePTHIT

45.2g powder Southeastern Region

Fentanyl (1.2%)Heroin5F-MDMB-PINACACyclopropyl fentanylCocaineLidocaineCaffeine

28g powder Southeastern Region

Heroin (1.5%)4-ChloroethcathinoneU-477002-Furanyl fentanylQuinineDiphenhydramineEtizolam

49g powder North Central Region

Complex Fentanyl MixturesNote: This data was acquired from exhibits analyzed by the DEA Laboratory System between 9/2/2018 through 1/5/2019.

Page 27: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Fentanyl and MarijuanaNote: This data was acquired from exhibits analyzed by the DEA Laboratory System.

Few identifications of THC and fentanyl• Majority were residue

(i.e. scales, paraphernalia)• None were described as plant material• No indications of marijuana and fentanyl

identified in the data set reviewed

Is marijuana being mixed or laced with fentanyl?

Page 28: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Laboratory Resources: Update

Searchable Libraries:

IR Library Version 2.0 – Updated 2/8/2019

MS Library Version 2.0 – Updated 1/31/19

Drug Monographs

Regularly updated

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 29: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

Summary• 22 NPS were identified for the first time in 2018 which equates to

approximately one new substance approximately every two and a half weeks.

• Approximately 33% of the synthetic opioids identified were seized and identified for the first time in 2018.

• Seized drug analyses can be a useful tool in understanding complex drug mixtures and their relationship to toxicological results.

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Page 30: Drug Threats in the United States: 2019 Update · 2019-03-13 · 2 1 1 1 1 2C-B 25I-NBOMe 25B-NBOMe 25C-NBOMe 2C 2C-I Hallucinogens 9 6 4 3 TFMPP BZP pFPP DBZP Piperazines 35 4 2

DEA SPECIAL TESTING AND RESEARCH LABORATORY

Thank You!

Jill M. HeadSupervisory Chemist

United States Drug Enforcement AdministrationSpecial Testing and Research Laboratory

[email protected]